SCIENTIFIC BACKGROUND

HTT

Huntington disease is an autosomal dominant inherited neurodegenerative disease with a prevalence of 5-7:100,000 in the Central European population. The average age disease onset is 40 years; children and the elderly patients are rarely affected. The symptoms are mainly movement disorders that become choreatic over time, character changes that range from frequent depressive moods and mental deterioration in the beginning to dementia due to atrophy of the caudate nucleus and the putamen or cortex. The disease has an average duration of 15 years.

 

The disease is caused by a CAG triplet repeat expansion in exon 1 of the HTT gene. Normal subjects have alleles with 6-26 CAG repeats; Huntington disease always occurs from 40 repeats onward. There is a certain statistic correlation between repeat length and the age of onset. Due to the CAG repeat expansion, increased glutamine residues are incorporated into the huntingtin protein. This leads to an aggregation of the proteins and thus to a disturbance of the physiological processes in the nerve cells. The mechanism by which atrophy only occurs in certain areas of the brain is not yet fully understood. There is no causal treatment available; movement disorders and psychological changes can be treated symptomatically.

 

In patients who already show symptoms, the symptomatic genetic diagnosis serves to ensure the clinical suspected diagnosis or the differential diagnosis.

 

Predictive diagnostics involves the examination of healthy individuals considered at risk, usually first degree relatives of those affected. According to the German Genetic Diagnostics Act (GenDG), genetic counselling should be offered with every diagnostic genetic examination. According to the GenDG, predictive genetic diagnostics require genetic counselling before the examination and after the results are available (§10, paragraph 2 GenDG). According to the recommendations of professional associations, psychotherapeutic care should be available before, during and after the examination phase.

 

References

Ghosh et al. 2018, Adv Exp Med Biol 1049:1 / McColgan et al. 2017, Eur J Neurol 25:24 / Nance 2017, Am J Med Genet B Neuropsychiatr Genet 174:75 / van der Burg et al. 2009, Lancet Neurol 8:765 / Walker 2007, Lancet 369:218 / McNeil et al. 1997, Hum Mol Genet 6:775 / Rubinsztein et al. 1996, Am J Hum Genet 59:16 / Gellera et al. 1996, Am J Hum Genet 59:475 / Huntington’s Disease Collaborative Research Group 1993, Cell 72:971

GENES

HTT

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more